ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 274 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $183,031,045 | -4.9% | 425,614 | -12.9% | 0.76% | +8.1% |
| Q1 2024 | $192,450,336 | -4.3% | 488,800 | -7.5% | 0.71% | -9.8% |
| Q4 2023 | $201,132,580 | +9.9% | 528,698 | +42.1% | 0.78% | -2.1% |
| Q3 2023 | $182,962,563 | -8.5% | 372,155 | -27.5% | 0.80% | -6.2% |
| Q2 2023 | $200,031,261 | -2.2% | 513,256 | -6.5% | 0.85% | -15.1% |
| Q1 2023 | $204,554,617 | +5.8% | 549,022 | +7.5% | 1.01% | -14.7% |
| Q4 2022 | $193,427,567 | +6.8% | 510,592 | -0.5% | 1.18% | +2.0% |
| Q3 2022 | $181,133,000 | -8.6% | 513,052 | -1.9% | 1.16% | -3.3% |
| Q2 2022 | $198,086,000 | +18.7% | 522,821 | -1.2% | 1.20% | +37.5% |
| Q1 2022 | $166,870,000 | +150.5% | 529,224 | +178.2% | 0.87% | +150.7% |
| Q4 2021 | $66,616,000 | – | 190,229 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |